Lotte Sondag

Lotte Sondag

Auto-generated profile, based on publicly available information

Lotte Sondag

Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center , Nijmegen

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2020 in Annals of Neurology
Verified
Journal Article
Open access
PDF file
LSLotte Sondag
Lotte Sondag
FSFloris H. B. M. Schreuder
Floris H. B. M. Schreuder
JBJeroen D Boogaarts
Jeroen D Boogaarts
MRMaroeska M. Rovers
Maroeska M. Rovers
WVW. Peter Vandertop
W. Peter Vandertop
TCthe Dutch ICH Surgery Trial Study Group part of the CONTRAST consortium
the Dutch ICH Surgery Trial Study Group part of the CONTRAST consortium
Objective: The effect of surgical treatment for supratentorial spontaneous intracerebral hemorrhage (ICH) and whether it is modified by key baseline characteristics and timing remains uncertain.Methods: We performed a systematic review and meta‐analysis of randomized controlled trials of surgical treatment of supratentorial spontaneous ICH aimed at clot removal. We searched MEDLINE, Embase, and Cochrane databases up to February 21, 2019. Primary outcome was good functional outcome at follow‐up; secondary outcomes were death and serious adverse events. We analyzed all types of surgery combined and minimally invasive approaches separately. We pooled risk ratios with 95% confidence intervals and assessed the modifying effect of age, Glasgow Coma Scale, hematoma volume, and timing of surgery with meta‐regression analysis.Results: We included 21 studies with 4,145 patients; 4 (19%) were of the highest quality. Risk ratio of good functional outcome after any type of surgery was 1.40 (95% confidence interval [CI] = 1.22–1.60, I2 = 46%, 20 studies), and after minimally invasive surgery it was 1.47 (95% CI = 1.26–1.72, I2 = 47%, 12 studies). For death, the risk ratio for any type of surgery was 0.77 (95% CI = 0.68–0.85, I2 = 23%, 21 studies), and for minimally invasive surgery it was 0.68 (95% CI = 0.56–0.83, I2 = 14%, 13 studies). Serious adverse events were reported infrequently. Surgery seemed more effective when performed sooner after symptom onset (p = 0.04, 12 studies). Age, Glasgow Coma Scale, and hematoma volume did not modify the effect of surgery.Interpretation: Surgical treatment of supratentorial spontaneous ICH may be beneficial, in particular with minimally invasive procedures and when performed soon after symptom onset. Further well‐designed randomized trials are needed to demonstrate whether (minimally invasive) surgery improves functional outcome after ICH and to determine the optimal time window of the treatment after symptom onset. ANN NEUROL 2020;88:239–250.

18 February 2023 in European Stroke Journal
Verified
Journal Article
Open access
MCMaaike P Cliteur
Maaike P Cliteur
LSLotte Sondag
Lotte Sondag
LCLaura Cunningham
Laura Cunningham
RSRustam Al-Shahi Salman
Rustam Al-Shahi Salman
NSNeshika Samarasekera
Neshika Samarasekera
FSFloris Hbm Schreuder
Floris Hbm Schreuder
Purpose: Perihaematomal oedema (PHO) formation has gained increasing interest as a therapeutic target after spontaneous intracerebral haemorrhage (ICH). Whether PHO contributes to poor outcome is unclear. We aimed to determine the association between PHO and outcome in patients with spontaneous ICH. Method: We searched five databases up to 17 November 2021 for studies of ⩾10 adults with ICH reporting the presence of PHO and outcome. We assessed risk of bias, extracted aggregate data and used random effects meta-analysis to pool studies that reported odds ratios (OR) with 95% confidence intervals (CI). Primary outcome was poor functional outcome defined as modified Rankin Scale score of 3–6 at 3 months. Additionally, we assessed PHO growth and poor outcome at any time of follow-up. We prospectively registered the protocol in PROSPERO (CRD42020157088). Findings: We identified 12,968 articles, of which we included 27 studies ( n = 9534). Eighteen studies reported an association between larger PHO volume and poor outcome, six a neutral result and three an inverse relationship. Larger absolute PHO volume was associated with poor functional outcome at 3 months (OR per mL increase of absolute PHO 1.03, 95% CI 1.00–1.06, I 2 44%, four studies). Additionally, PHO growth was associated with poor outcome (OR 1.04, 95% CI 1.02–1.06, I 2 0%, seven studies). Discussion: In patients with spontaneous ICH, larger PHO volume is associated with poor functional outcome at 3 months. These findings support the development and investigation of new therapeutic interventions targeting PHO formation to evaluate if reduction of PHO improves outcome after ICH.

12 July 2019 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
JWJoyce Wilbers
Joyce Wilbers
LSL. Sondag
L. Sondag
SMS. Mulder
S. Mulder
BSB. Siegerink
B. Siegerink
EDE. J. van Dijk
E. J. van Dijk
TGthe Dutch String‐of‐Pearls Stroke Study Group
the Dutch String‐of‐Pearls Stroke Study Group
Background and purpose: The aim of this study was to assess the prevalence of cancer and its characteristics in patients with ischemic stroke and to compare this with cancer prevalence in the general population.Methods: This was a multicenter cohort study with 2736 patients presenting with ischemic stroke or transient ischemic attack. The prevalence of cancer was assessed by interview and verified by reviewing all medical records. In stroke patients with a history of cancer, we studied the subtype of cancer and its treatment characteristics. We used the national database of The Netherlands Cancer Registry to calculate population‐based age and sex cancer standardized prevalence ratios (SPRs) for patients with ischemic stroke.Results: Cancer prevalence in ischemic stroke patients was 12%, corresponding to an SPR of 1.2 [95% confidence interval (CI), 1.0–1.3]. Increased SPRs were observed for cancer of the central nervous system (SPR, 18.2; 95% CI, 9.0–27.4), head and neck (SPR, 3.4; 95% CI, 2.3–4.6), lower respiratory tract (SPR, 2.4; 95% CI, 1.5–3.3) and urinary tract (SPR, 2.1; 95% CI, 1.4–2.9), but not for other cancer types. Cardiovascular risk factors, stroke etiology, treatment and outcome were not different between patients with or without a history of cancer.Conclusions: In stroke patients, the prevalence of cancer, most prominently cancer of the central nervous system, head and neck, lower respiratory and urinary tract, was higher than in the general population. Medical treatment for the prevention of stroke in cancer survivors deserves further study.

1 June 2021 in European Stroke Journal
Verified
Journal Article
Open access
PDF file
LSLotte Sondag
Lotte Sondag
FJFloor Ae Jacobs
Floor Ae Jacobs
FSFloris Hbm Schreuder
Floris Hbm Schreuder
JBJeroen D Boogaarts
Jeroen D Boogaarts
WVW Peter Vandertop
W Peter Vandertop
CKCatharina Jm Klijn
Catharina Jm Klijn
Introduction: The role of surgery in spontaneous intracerebral haemorrhage (sICH) remains controversial. This leads to variation in the percentage of patients who are treated with surgery between countries. Patients and methods: We sent an online survey to all neurosurgeons (n = 140) and to a sample of neurologists (n = 378) in Dutch hospitals, with questions on management in supratentorial sICH in general, and on treatment in six patients, to explore current variation in medical and neurosurgical management. We assessed patient and haemorrhage characteristics influencing treatment decisions. Results: Twenty-nine (21%) neurosurgeons and 92 (24%) neurologists responded. Prior to surgery, neurosurgeons would more frequently administer platelet-transfusion in patients on clopidogrel (64% versus 13%; p = 0.000) or acetylsalicylic acid (61% versus 11%; p = 0.000) than neurologists. In the cases, neurosurgeons and neurologists were similar in their choice for surgery as initial treatment (24% and 31%; p = 0.12), however variation existed amongst physicians in specific cases. Neurosurgeons preferred craniotomy with haematoma evacuation (74%) above minimally-invasive techniques (5%). Age, Glasgow Coma Scale score and ICH location were important factors influencing decisions on treatment for neurosurgeons and neurologists. 69% of neurosurgeons and 80% of neurologists would randomise patients in a trial evaluating the effect of minimally-invasive surgery on functional outcome. Discussion: Our results reflect the lack of evidence about the right treatment strategy in patients with sICH. Conclusion: New high quality evidence is needed to guide treatment decisions for patients with ICH. The willingness to randomise patients into a clinical trial on minimally-invasive surgery, contributes to the feasibility of such studies in the future.

21 November 2023 in Wellcome Open Research
Verified
Journal Article
Open access
CKCaoimhe Kirby
Caoimhe Kirby
JBJack Barrington
Jack Barrington
LSLotte Sondag
Lotte Sondag
JLJames JM Loan
James JM Loan
FSFloris H.B.M. Schreuder
Floris H.B.M. Schreuder
NSNeshika Samarasekera
Neshika Samarasekera
Background Currently, there are no specific medical treatments for intracerebral haemorrhage (ICH), but the inflammatory response may provide a potential route to treatment. Given the known effects of acute brain injury on peripheral immunity, we hypothesised that inflammatory biomarkers in peripheral blood may be associated with clinical outcome following ICH, as well as perihaematomal oedema (PHO), which is an imaging marker of the neuroinflammatory response. Methods We searched OVID Medline and EMBASE on 07 April 2021 for studies of humans with ICH measuring an inflammatory biomarker in peripheral blood and PHO or clinical outcome. Risk of bias was assessed both by using a scale comprising features of the Newcastle-Ottawa Assessment Scale, STROBE-ME and REMARK guidelines, and for studies included in meta-analysis, also by the QUIPS tool.We used random effects meta-analysis to pool standardised mean differences (SMD) if ≥1 study quantified the association between identical biomarkers and measures of PHO or functional outcome. Results Of 8,615 publications, 16 examined associations between 21 inflammatory biomarkers and PHO (n=1,299 participants), and 93 studies examined associations between ≥1 biomarker and clinical outcome (n=17,702 participants). Overall, 20 studies of nine biomarkers (n=3,199) met criteria for meta-analysis of associations between inflammatory biomarkers and clinical outcome. Death or dependency (modified Rankin Scale (mRS) 3‒6) 90 days after ICH was associated with higher levels of fibrinogen (SMD 0.32; 95%CI [0.04, 0.61]; p=0.025), and high mobility group box protein 1 (HMGB1) (SMD 1.67; 95%CI [0.05, 3.30]; p=0.04). Higher WBC was associated with death or dependency at 90 days (pooled SMD 0.27; 95% CI [0.11, 0.44]; p=0.001; but the association was no longer significant when the analysis was restricted to studies with a low risk of bias (pooled SMD 0.22; 95% CI -0.04-0.48). Higher CRP seemed to be associated with death or dependency at 90 days (pooled SMD 0.80; 95% CI [0.44, 1.17]; p<0.0001) but this association was no longer significant when adjusted OR were pooled (OR 0.99 (95% CI 0.98-1.01)). Conclusions Higher circulating levels of, fibrinogen and HMGB1 are associated with poorer outcomes after ICH. This study highlights the clinical importance of the inflammatory response to ICH and identifies additional research needs in determining if these associations are mediated via PHO and are potential therapeutic targets. Registration PROSPERO (CRD42019132628; 28/05/2019).

1 March 2026 in European Stroke Journal
Verified
Journal Article
Open access
FWFloor N H Wilting
Floor N H Wilting
JDJules Peter Jan Douwes
Jules Peter Jan Douwes
APAjay Patel
Ajay Patel
FSFloris H B M Schreuder
Floris H B M Schreuder
RDRuben Dammers
Ruben Dammers
CKCatharina J M Klijn
Catharina J M Klijn
Introduction: Precise volumetric evaluation of intracerebral haemorrhage (ICH), intraventricular haemorrhage (IVH) and perihaematomal oedema (PHO) is essential but manual segmentation is time-consuming and susceptible to variability. We aimed to develop and externally validate a deep learning model for simultaneous segmentation of ICH, IVH and PHO on non-contrast CT (NCCT) in patients with spontaneous ICH. Patients and methods: A 3D U-net model was trained with 5-fold cross-validation on baseline NCCTs from 301 patients included in 2 prospective multicentre studies. External validation was performed on 141 baseline NCCTs from another multicentre study. Model performance was evaluated against manual ground truth segmentations using the Dice similarity coefficient (DSC), intraclass correlation coefficients (ICC) and Bland–Altman analyses. Results: The model achieved a median DSC of 0.93 (IQR 0.91–0.94) for ICH, 0.75 (IQR 0.57–0.82) for IVH and 0.53 (IQR 0.34–0.65) for PHO. Volume correlations were excellent for ICH (mean absolute and consistency ICC both 0.98 [95% CI 0.98–0.99]) and IVH (absolute ICC 0.97 [95% CI 0.92–0.98]; consistency ICC 0.98 [95% CI 0.96–0.99]), and moderate for PHO (absolute ICC 0.60 [95% CI -0.08–0.85]; consistency ICC 0.82 [95% CI 0.76–0.87]). Bland–Altman analyses demonstrated a bias for ICH of −0.48 mL (LoA −8.21 to 7.26), for IVH of −1.68 mL (LoA −7.35 to 3.99) and for PHO of 13.91 mL (LoA −4.85 to 32.68). Discussion and conclusion: The model enables accurate automated segmentation of ICH, while IVH and PHO segmentation remain more challenging. Automated segmentations may already serve as reliable pre-segmentations in research, but require visual assessment and correction, in particular for IVH and PHO.